The global human milk oligosaccharides market has been divided, by application, into infant formula, dietary supplements, and others. The infant formula segment is projected to be dominant and register the highest growth rate during the review period due to the rising concerns regarding infant nutrition. HMOs help in promoting infant gut health as these oligosaccharides are indigestible by the human body and thus act as a food source for intestinal bacteria, especially bifidobacteria. Moreover, changing lifestyles have led to the increasing prevalence of complications such as premature birth and reduced or no production of breast milk. This has resulted in neonatologists and parents focusing on infant nutrition, which in turn, is boosting the demand for HMOs.
Human milk oligosaccharides (HMOs) are dense sugars found predominantly in human breast milk. These complex sugar molecules or oligosaccharides act as an energy source for the microbiomes in the human body. They also help in reducing the risk of allergies and inflammation, protecting neonates from viral and bacterial infections, and promoting cognitive health. Manufacturers of HMOs are focusing on R&D to improve the production process and quality so as to qualify these products as functional food ingredients. However, market players are witnessing certain challenges in the chemical production of HMOs due to its complexity and low production volumes.
Get a Free Sample of This Report Here @ https://www.marketresearchfuture.com/sample_request/7843
The global human milk oligosaccharides market has been segmented by type, application, and region.
Based on type, the global human milk oligosaccharides market has been segmented into 2’-Fucosyllactose (2’FL), Lacto-N-neotetraose (LNnT), and others. The 2’FL segment is expected to garner the largest revenue share as 2’FL is present in high concentrations in human breast milk. It helps in reducing the risk of infection from widespread bacterial diarrheal pathogens and pneumonia-causing pathogens. Additionally, the consumption of 2’FL promotes cognitive and neural health. LNnT is also a significant oligosaccharide found in human breast milk and is usually added in infant formula along with 2’FL.
Some of the key players in the global human milk oligosaccharides market are Glycosyn LLC (US), Inbiose NV (Belgium), ZuChem Inc. (US), BASF SE (Germany), DowDuPont (US), Glycom A/S (Denmark), Elicityl S.A. (France), Royal FrieslandCampina (Netherlands), Medolac Laboratories (US), and Jennewein Biotechnologie GmbH (Germany).
The global Human Milk Oligosaccharides Market has been segmented, on the basis of region, into North America, Europe, Asia-Pacific, the rest of the world.
North America is expected to gain the largest market share during the review period owing to a focus on infant nutrition with increased spending on childcare in the region. The limited presence of milk banks in the US and Canada has led to low collection of human breast milk, affecting the supply of donor milk. Thus, the demand for infant formula with HMOs is growing in the region.